Publications by authors named "Alaina C Larson"

Claim this Profile
M
M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.
Gabrielle L Brumfield, Kenadie R Doty, Shelby M Knoche, Alaina C Larson, Benjamin D Gephart

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid precursor-like protein 2 expression in macrophages: differentiation and M1/M2 macrophage dynamics.
Gabrielle L Brumfield, Shelby M Knoche, Kenadie R Doty, Alaina C Larson, Brittany J Poelaert

Front Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor.
Shelby M Knoche, Alaina C Larson, Gabrielle L Brumfield, Steven Cate, William H Hildebrand

Immunol Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer.
Alaina C Larson, Kenadie R Doty, Joyce C Solheim

Cancer Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells.
Alaina C Larson, Shelby M Knoche, Gabrielle L Brumfield, Kenadie R Doty, Benjamin D Gephart

Int J Mol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert.
Xiaoqi Li, Mansi Gulati, Alaina C Larson, Joyce C Solheim, Maneesh Jain

Semin Cancer Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
Shelby M Knoche, Gabrielle L Brumfield, Benjamin T Goetz, Bailee H Sliker, Alaina C Larson

PLoS One· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor.
Shelby M Knoche, Alaina C Larson, Gabrielle L Brumfield, Steven Cate, William H Hildebrand

Immunol Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring Our Approach in Response to the SARS-CoV-2 Pandemic and Transcending Science Outreach Modalities for Native American Students in a Cancer Research Education Program.
Aislinn C Rookwood, Liliana P Bronner, Mariah A Abney, Hannah S Butler-Robbins, Misty S Pocwierz-Gaines, Alaina C Larson

J STEM Outreach· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of tumor heterogeneity in immune-tumor interactions.
Shelby M Knoche, Alaina C Larson, Bailee H Sliker, Brittany J Poelaert, Joyce C Solheim

Cancer Metastasis Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer.
Brittany J Poelaert, Shelby M Knoche, Alaina C Larson, Poomy Pandey, Parthasarathy Seshacharyulu

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis